Carnitine Supplementation and VLCAD Deficiency There has been considerable controversy regarding the role of Lcarnitine (Carnitor®, Sigma-Tau Pharmaceuticals, Inc.) and its value as a supplemental therapy in fat oxidati - Very long chain fatty acid - Document - PDFSEARCH.IO

First Page	Meta Content
	Carnitine Supplementation and VLCAD Deficiency There has been considerable controversy regarding the role of Lcarnitine (Carnitor®, Sigma-Tau Pharmaceuticals, Inc.) and its value as a supplemental therapy in fat oxidati Add to Reading List Document Date: 2012-05-31 13:41:07 Open Document File Size: 38,35 KB Share Result on Facebook Company Sigma-Tau Pharmaceuticals Inc. / / MedicalCondition recurrent rhabdomyolysis / VLCAD Deficiency / inherited disorder / fat oxidation disorders / unexpected illness / long-chain fat oxidation disorders / adult onset CPTII Deficiency / disease / / Person Alfred Slonim / / Product Carnitor / / SocialTag Dietary supplements Quaternary ammonium compounds Medium-chain acyl-coenzyme A dehydrogenase deficiency Carnitine Very long-chain acyl-coenzyme A dehydrogenase deficiency Rare diseases Fatty-acid metabolism disorder Inborn error of lipid metabolism Health Chemistry

Carnitine Supplementation and VLCAD Deficiency There has been considerable controversy regarding the role of Lcarnitine (Carnitor®, Sigma-Tau Pharmaceuticals, Inc.) and its value as a supplemental therapy in fat oxidatiAdd to Reading List